Evaluation of the German guideline for chronic pruritus: Results of a retrospective study on 385 patients

Dermatology

Volumn 223, Issue 4, 2012, Pages 374-380

  Siepmann, D ^a   Weishaupt, C ^a   Luger, T A ^a   Stander S ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antipruritic therapy; Evidence level; Health economics; Itch; Randomized controlled trials

Indexed keywords

ANTIPRURITIC AGENT; ANXIOLYTIC AGENT; CAPSAICIN; CYCLOSPORIN A; FEXOFENADINE; FLUVOXAMINE; GABAPENTIN; GLUCOCORTICOID; LEVOCETIRIZINE; NALTREXONE; NEUROLEPTIC AGENT; PAROXETINE; PREGABALIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CHILD; CHRONIC DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DIZZINESS; ECONOMIC ASPECT; FATIGUE; FEMALE; GERMANY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPRURITICS; CHILD; CHRONIC DISEASE; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRURITUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858442431     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000335782     Document Type: Article

References (15)

1. Matterne U, Strassner T, Apfelbacher CJ, et al: Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in largescale studies. Acta Derm Venereol 2009; 89: 250-256.
2. Ständer S, Schäfer I, Phan NQ, et al: Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 2010; 221: 229-235.
3. Tey HL, Yosipovitch G: Targeted treatment of pruritus: a look into the future. Br J Dermatol 2011; 165: 5-17.
4. Raap U, Ständer S, Metz M: Pathophysiology of itch and new treatments. Curr Opin Allergy Clin Immunol 2011; 11: 420-427.
5. Ständer S, Streit M, Darsow U, et al: Diagnostic and therapeutic procedures in chronic pruritus (in German). J Dtsch Dermatol Ges 2006; 4: 350-370.
6. Ständer S, Weisshaar E, Mettang T, et al: Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87: 291-294.
7. Schulz S, Metz M, Siepmann D, et al: Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series. Hautarzt 2009; 60: 564-568.
8. Wang J, Ishii T, Zhang W, et al: Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms. Leukemia 2009; 23: 1577-1586.
9. Abdel-Naser MB, Zaki MS, Mousa MH, et al: Cutaneous mononuclear cells and eosinophils are significantly increased after warm water challenge in pruritic areas of polycythemia vera. J Cutan Pathol 2007; 34: 924-929.
10. Diehn F, Tefferi A: Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol 2001; 115: 619-621.
11. Phan NQ, Bernhard JD, Luger TA, Ständer S: Antipruritic treatment with systemic -opioid receptor antagonists: a review. J Am Acad Dermatol 2010; 19: 58-65.
12. Ständer S, Raap U, Weisshaar E, et al: Pathogenesis of pruritus. J Dtsch Dermatol Ges 2011; 9: 456-463.
13. Aupperle RL, Ravindran L, Tankersley D, et al: Pregabalin influences insula and amygdala activation during anticipation of emotional images. Neuropsychopharmacology 2011; 36: 1466-1477.
14. Tzellos TG, Papazisis G, Toulis KA, et al: A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia 2010; 14: 71-75.
15. Naldi L, Mercuri SR: Chronic pruritus management: A plea for improvement - can itch clinics be an option? Dermatology 2010; 221: 216-218.